ProQR Announces Third Quarter 2026 Operating and Financial ResultsNoticia de empresa12 nov 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming ConferencesNoticia de empresa28 oct 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI AdvisorNoticia de empresa23 sept 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026Noticia de empresa9 sept 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR to Participate in Upcoming Investor Conferences in September 2026Noticia de empresa2 sept 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces Second Quarter 2026 Operating and Financial ResultsNoticia de empresa13 ago 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing PlatformNoticia de empresa25 jun 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private PlacementNoticia de empresa25 jun 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces First Quarter 2026 Operating and Financial ResultsNoticia de empresa12 may 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing PlatformNoticia de empresa11 may 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026Noticia de empresa4 may 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of DirectorsNoticia de empresa30 abr 2026ENProQR Therapeutics N.V.Company announcement feed
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst EventNoticia de empresa8 abr 2026ENProQR Therapeutics N.V.Company announcement feed